Michael Jensen is the Vice President and Chief Therapeutics Officer, at Seattle Children’s Health System. He is an internationally recognized leader in the field of CAR T-cell cancer immunotherapy with over 20 years of experience in the research and clinical translation of this therapeutic modality. He has focused on the applications to childhood cancers. Dr. Jensen graduated from the University of Pennsylvania School of Medicine and then completed training in Pediatric Hematology and Oncology at the University of Washington/Fred Hutchinson Cancer Research Center with a focus on the immunobiology of tumor-specific T-cells. In 2010, Dr. Jensen returned to Seattle and joined the University of Washington School of Medicine faculty as a Professor of Pediatrics and Adjunct Professor of Bioengineering and was the founding director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute.